Pricing Log in Create free account
Friday 6 November 2026 Export NGVT’s income statement to Excel — free account

Ingevity Corporation

NGVT Basic Materials Specialty Chemicals

Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.

Revenue
−5.25%
EPS
+125.4%
Free cash flow
−136.1%
Total debt
−14.5%

Quarter to June 2026, against a year earlier

64.75 8.98 −12.18%
Market cap
$2.2B
P/E
42.0×
Fwd P/E
18.4×
Dividend yield
—
F-score
6/9
Altman Z
1.84
Beneish M
−4.00
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 1.76
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — 1 — — 3 — — —
Insider Ownership 2.22%

Capital & Financial Ratios $m

Size
Market Cap 2,190.00
Revenue ttm 1,160.30
Net income ttm 54.00
Free cash flow ttm 154.90
Net debt Q 873.00
Valuation
P/E 42.05 (above 35: high)
Forward P/E 18.40
Price / sales 1.94
Forward P/S Powerpack
Price / FCF 14.50
Price / book 47.89 (above 6: high)
Financial health
Current ratio Q 1.61 (at or above 1.5: strong)
Debt / equity Q 22.52 (above 2: weak)
Interest coverage Q 4.23
Growth
Revenue growth Q −5.25% (below 0%: shrinking)
Operating income growth Q +152.81% (above 0%: growing)
EPS, this year +18.53% (at or above 15%: strong)
EPS, next year A +10.57%
Revenue, next year A −4.93% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A +14.53%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 2.7×, against a ten-year median of 2.8×; over the ten years it ranged from 1.4× in 2016 to 5.3× in 2019.
P/E against its own 10 years 83.07%
10-year low 10-year high
P/S against its own 10 years 42.55%
10-year low 10-year high
P/B against its own 10 years 91.94%
10-year low 10-year high
EV/Sales against its own 10 years 40.36%
10-year low 10-year high
EV/FCF against its own 10 years 27.69%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 96 68 78 183
Receivables 182 132 127 156
Inventory 309 196 186 154
Other — — — —
659 493 454 544
2023 2024 2025 Q'26
Payables 158 95 92 88
ST’ Debt — — — —
Other — — — —
363 264 341 338

Compound Annual Growth %

10y 5y 3y
Sales 2.00% (0.81%) (11.21%)
Cash Flow 16.45% (1.23%) 1.86%
Earnings 0.00% 0.00% 0.00%
Book Value (24.86%) (45.92%) (65.09%)

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 1.56 Actual 1.63

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.74 0.58 Miss by 0.16
Q1 FY26 0.84 1.15 Beat by 0.31
Q2 FY26 1.31 1.74 Beat by 0.43
Q3 FY26 1.56 1.63 Beat by 0.07
Q4 FY26 0.95 — Reports 24 February 2027

EPS $

Mar Jun Sep Dec Year
’26 1.66 1.00 — — —
’25 0.56 (4.02) 1.18 (2.37) (4.61)
’24 (1.54) (7.81) (2.95) 0.46 (11.85)
’23 1.35 0.97 0.69 (3.23) (0.15)
’22 1.55 1.54 1.98 0.41 5.50
’21 1.20 1.10 (0.11) 0.74 2.95
’20 1.08 0.49 1.69 1.23 4.48
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 258 314 — — —
’25 248 332 333 255 1,168
’24 340 391 334 136 1,200
’23 393 482 446 372 1,216
’22 383 420 482 384 1,668
’21 320 358 377 336 1,392
’20 288 271 332 326 1,216
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (14) — — —
’25 25 79 130 97 331
’24 (12) 30 47 65 129
’23 5 48 105 46 205
’22 24 91 100 99 313
’21 51 66 100 76 293
’20 60 49 90 153 352
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (12) (24) — — —
’25 19 67 114 77 277
’24 (29) 12 29 40 51
’23 (20) 27 72 17 95
’22 (3) 61 64 49 171
’21 34 42 75 39 190
’20 41 34 74 122 270
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.5
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 908 972 1,134 1,293 1,216 1,392 1,668 1,216 1,200 1,168 1,160 +2.8% 1,110 1,130 1,153 (0.4%)
Gross margin, % 30.21 33.83 36.77 37.28 38.28 36.85 34.17 36.61 38.73 39.53 41.13 +9.3 pt
EBT 87 175 222 228 235 163 270 130 (140) (142) 38 n/m
EBT margin, % 9.58 17.98 19.57 17.63 19.33 11.70 16.16 10.70 (11.71) (12.17) 3.26 (21.7) pt
Net income 44 145 182 184 181 118 212 (5) (430) (167) 54 n/m
Per share, $
Per share, $ Revenue 21.57 23.08 26.97 30.93 29.42 34.95 43.70 33.31 33.04 32.23 33.45 +4.6%
Earnings 0.83 3.00 4.03 4.39 4.51 2.97 5.54 (0.15) (11.85) (4.61) 1.54 n/m
Cash flow 3.04 4.14 5.99 6.60 8.53 7.37 8.21 5.62 3.54 9.14 6.08 +13.0%
Capex (1.35) (1.25) (2.23) (2.75) (1.99) (2.61) (3.73) (3.01) (2.14) (1.49) (1.62) +1.2%
Free cash flow 1.69 2.89 3.76 3.85 6.54 4.76 4.48 2.61 1.40 7.65 4.47 +18.3%
Book value 3.20 6.60 8.06 12.70 15.54 16.92 18.29 17.30 5.37 0.82 1.35 (14.0%)
Shares, m 42 42 42 42 41 40 38 36 36 36 36 (1.7%)
Valuation, ×
Valuation, × P/E 66.48 23.72 20.77 19.95 16.79 24.31 12.87 0.00 0.00 0.00 42.05 18.5
P/S 2.47 3.07 3.10 2.83 2.57 2.05 1.63 1.01 1.23 1.84 1.94 2.2
P/B 16.64 10.75 10.39 6.88 4.87 4.24 3.88 2.72 7.58 72.18 47.89 14.0
EV/Sales 2.97 3.45 3.71 3.75 3.42 2.77 2.47 1.78 2.31 2.78 2.70 2.9
EV/FCF 37.89 27.55 26.57 30.10 15.38 20.31 24.14 31.69 54.33 11.71 20.26 28.0
Cash, $m
Cash, $m Operating cash flow 128 174 252 276 352 293 313 205 129 331 211 +11.2%
Capex (57) (53) (94) (115) (82) (104) (142) (110) (78) (54) (56) (0.5%)
Free cash flow 71 122 158 161 270 190 171 95 51 277 155 +16.3%
Balance, $m
Balance, $m Working capital 158 216 239 248 405 456 380 296 229 113 206 (3.7%)
Net debt 458 366 664 1,172 1,010 975 1,396 1,287 1,272 1,083 873 +10.0%
Shareholders’ equity 135 278 339 531 642 674 698 631 195 30 47 (15.5%)
Returns, %
Returns, % ROA 4.37 14.36 15.07 10.63 8.11 0.00 8.13 (0.20) (18.52) (9.10) 3.16 (13.5) pt
ROIC 10.72 18.56 15.75 9.93 10.34 11.01 9.62 6.54 (1.81) (2.47) 9.33 (13.2) pt
ROE 10.80 61.33 54.85 42.25 30.93 0.00 30.84 (0.81) (104.11) (148.60) 64.44 (159.4) pt
People
People Employees 1,500 1,500 1,750 1,850 1,750 1,850 2,050 1,700 1,600 1,500 — 0.0%
Revenue/emp, $m 0.61 0.65 0.65 0.70 0.69 0.75 0.81 0.72 0.75 0.78 — +2.8%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 24 Oct 2026

Ingevity Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HWKN Hawkins, Inc. $3.2B 36.6× 36.3× +11.90% (above 0%: growing) +23.06% (above 0%: growing) +1.32% (above 0%: growing) 24.41% 13.35% Compare
WDFC WD-40 Company $3.0B 37.0× 32.3× +8.14% (above 0%: growing) −31.85% (below 0%: shrinking) +63.49% (above 0%: growing) 52.78% 10.78% Compare
FUL H. B. Fuller Company $2.7B 13.8× 11.7× +5.17% (above 0%: growing) +18.19% (above 0%: growing) −58.41% (below 0%: shrinking) 33.22% 12.07% Compare
KWR Quaker Houghton $2.6B 27.2× 21.6× +10.27% (above 0%: growing) −0.42% (below 0%: shrinking) −92.40% (below 0%: shrinking) 35.54% 8.97% Compare
NGVT Ingevity Corporation $2.2B 42.0× 18.4× −5.25% (below 0%: shrinking) n/m −136.08% (below 0%: shrinking) 44.25% 19.13%
IOSP Innospec Inc. $2.0B 13.9× 19.5× +7.17% (above 0%: growing) +146.71% (above 0%: growing) −88.68% (below 0%: shrinking) 27.26% 8.80% Compare
MTX Minerals Technologies Inc. $1.9B — (loss-making) — (loss-making) +4.23% (above 0%: growing) +2.80% (above 0%: growing) +19.04% (above 0%: growing) 23.28% 11.68% Compare
CC The Chemours Company $1.9B — (loss-making) — (loss-making) +3.01% (above 0%: growing) +223.80% (above 0%: growing) −12.50% (below 0%: shrinking) 15.00% 14.87% Compare
STDN Standard Nuclear Inc $1.8B — — — n/m — 67.21% (90.70%) Compare
Median of peers $2.3B 27.2× 21.6× +7.17% +18.19% −12.50% 30.24% 11.23%

All 61 Specialty Chemicals stocks →

Ingevity Corporation (NGVT) Latest News

5 Nov

Impact 3 · · The Motley Fool transcript

4 Nov

Impact 3 · · Business Wire

15 Oct

Impact 4 · · Zacks

7 Oct

Impact 4 · · Zacks

30 Sep

Impact 4 · · Zacks

27 Sep

Impact 4 · · MarketBeat

23 Sep

Impact 4 · · Simply Wall St.

22 Sep

Impact 3 ·

7 Aug

Impact 3 · · The Motley Fool transcript

6 Aug

Impact 3 ·

2 Aug

Impact 4 ·

31 Jul

Impact 3 · · MarketBeat transcript

30 Jul

Impact 3 ·
Impact 3 · · Moby

29 Jul

Impact 3 ·

17 Jul

Impact 3 ·

11 Jun

Impact 3 ·

1 Jun

Impact 4 · · The Motley Fool transcript

13 May

Impact 4 · · MarketBeat

12 May

Impact 4 · · Zacks

9 May

Impact 4 · · Simply Wall St.

7 May

Impact 4 · · Moby

6 May

Impact 4 · · Zacks
Impact 4 · · Business Wire

3 May

Impact 4 · · MarketBeat

30 Apr

Impact 3 ·

29 Apr

Impact 3 · · Simply Wall St.

16 Apr

Impact 4 · · Zacks

15 Apr

Impact 4 · · Business Wire

11 Apr

Impact 4 · · Simply Wall St.

NGVT metrics, ten years each

stockrow.com/NGVT · Data as of Oct 24, 2026 · For information only; not investment advice. · © 2026 stockrow.com